Cargando…

First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan

Reports on the expenditure of cancer treatments per patient using comprehensive data remain unavailable in Japan. This study aimed to use Japan’s cancer registry data and health service utilization data for evaluating the disease-specific, per-patient costs of five major cancers—stomach, lung, color...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Tomone, Goto, Rei, Yamamoto, Yoko, Ichinose, Yuichi, Higashi, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466127/
https://www.ncbi.nlm.nih.gov/pubmed/34574371
http://dx.doi.org/10.3390/ijerph18189447
_version_ 1784573053303259136
author Watanabe, Tomone
Goto, Rei
Yamamoto, Yoko
Ichinose, Yuichi
Higashi, Takahiro
author_facet Watanabe, Tomone
Goto, Rei
Yamamoto, Yoko
Ichinose, Yuichi
Higashi, Takahiro
author_sort Watanabe, Tomone
collection PubMed
description Reports on the expenditure of cancer treatments per patient using comprehensive data remain unavailable in Japan. This study aimed to use Japan’s cancer registry data and health service utilization data for evaluating the disease-specific, per-patient costs of five major cancers—stomach, lung, colorectal, liver, and breast cancers. We used a database linking the 2017 data from a hospital-based cancer registry and the health service utilization data from the Diagnosis Procedure Combination survey. All patients who started their first treatment course at each hospital were included. The costs were calculated using the total volume of the health services provided and the unit fee information included in the data. We analyzed 304,698 patients. Lung cancer had the highest healthcare cost per-patient for the first year of diagnosis and the longest median hospitalization duration. Conversely, breast cancer showed the lowest cost and the shortest median hospitalization duration. However, in the first month after diagnosis, colorectal cancer showed the highest cost. Subsequently, the gaps between the costs of the five common cancers drastically diminished. The cancer type having the longest hospitalization duration had the highest overall healthcare resource utilization costs. This information is essential for care planning and research studies.
format Online
Article
Text
id pubmed-8466127
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84661272021-09-27 First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan Watanabe, Tomone Goto, Rei Yamamoto, Yoko Ichinose, Yuichi Higashi, Takahiro Int J Environ Res Public Health Article Reports on the expenditure of cancer treatments per patient using comprehensive data remain unavailable in Japan. This study aimed to use Japan’s cancer registry data and health service utilization data for evaluating the disease-specific, per-patient costs of five major cancers—stomach, lung, colorectal, liver, and breast cancers. We used a database linking the 2017 data from a hospital-based cancer registry and the health service utilization data from the Diagnosis Procedure Combination survey. All patients who started their first treatment course at each hospital were included. The costs were calculated using the total volume of the health services provided and the unit fee information included in the data. We analyzed 304,698 patients. Lung cancer had the highest healthcare cost per-patient for the first year of diagnosis and the longest median hospitalization duration. Conversely, breast cancer showed the lowest cost and the shortest median hospitalization duration. However, in the first month after diagnosis, colorectal cancer showed the highest cost. Subsequently, the gaps between the costs of the five common cancers drastically diminished. The cancer type having the longest hospitalization duration had the highest overall healthcare resource utilization costs. This information is essential for care planning and research studies. MDPI 2021-09-07 /pmc/articles/PMC8466127/ /pubmed/34574371 http://dx.doi.org/10.3390/ijerph18189447 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Watanabe, Tomone
Goto, Rei
Yamamoto, Yoko
Ichinose, Yuichi
Higashi, Takahiro
First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan
title First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan
title_full First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan
title_fullStr First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan
title_full_unstemmed First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan
title_short First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan
title_sort first-year healthcare resource utilization costs of five major cancers in japan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466127/
https://www.ncbi.nlm.nih.gov/pubmed/34574371
http://dx.doi.org/10.3390/ijerph18189447
work_keys_str_mv AT watanabetomone firstyearhealthcareresourceutilizationcostsoffivemajorcancersinjapan
AT gotorei firstyearhealthcareresourceutilizationcostsoffivemajorcancersinjapan
AT yamamotoyoko firstyearhealthcareresourceutilizationcostsoffivemajorcancersinjapan
AT ichinoseyuichi firstyearhealthcareresourceutilizationcostsoffivemajorcancersinjapan
AT higashitakahiro firstyearhealthcareresourceutilizationcostsoffivemajorcancersinjapan